PETALING JAYA: As excitement grows over the expected maiden arrival of the Pfizer-BioNTech vaccine tomorrow, security experts do not foresee any security issue arising from the delivery of the prized vaccine, especially for the first phase of the delivery.
However, anti-terrorist specialist and supply chain, transportation and facilities specialist Verghese Thirumala urged proper security measures to be put in place during the second phase of the delivery, when the vaccine is poised for wider distribution across the country.